ICU Medical, Inc. (ICUI) Tops Q3 EPS by 14c; Issues Mixed FY12 Outlook
ICU Medical, Inc. (NASDAQ: ICUI) reported Q3 EPS of $0.82, $0.14 better than the analyst estimate of $0.68. Revenue for the quarter came in at $81.4 million versus the consensus estimate of $81.42 million.
ICU Medical, Inc. sees FY2012 EPS of $2.75-2.80, versus prior guidance of $2.55-2.70 and the consensus of $2.60. ICU Medical, Inc. sees FY2012 revenue of $315-318 million, versus prior guidance of $318-325 million and the consensus of $320.28 million.
For earnings history and earnings-related data on ICU Medical, Inc. (ICUI) click here.
ICU Medical, Inc. sees FY2012 EPS of $2.75-2.80, versus prior guidance of $2.55-2.70 and the consensus of $2.60. ICU Medical, Inc. sees FY2012 revenue of $315-318 million, versus prior guidance of $318-325 million and the consensus of $320.28 million.
For earnings history and earnings-related data on ICU Medical, Inc. (ICUI) click here.